Gonal-f RFF Redi-ject
These highlights do not include all the information needed to use Gonal-f RFF Redi-ject safely and effectively. See full prescribing information for Gonal-f RFF Redi-ject Gonal-f RFF* Redi-ject (follitropin alfa injection) for subcutaneous use *revised formulation female Initial U.S. Approval: 1997
b6d11c45-b502-478e-bb28-2ff596ea259c
HUMAN PRESCRIPTION DRUG LABEL
Feb 2, 2022
EMD Serono, Inc.
DUNS: 088514898
Products 3
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
FOLLITROPIN
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (7)
FOLLITROPIN
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (7)
FOLLITROPIN
Product Details
FDA regulatory identification and product classification information